Skip to main content
SpringerLink
Log in

X-Linked Lymphoproliferative Disease

  • Chapter
Infectious Causes of Cancer

Part of the book series: Infectious Disease ((ID))

  • 239 Accesses

Abstract

The disease discussed in this chapter was discovered 30 yr ago at the autopsy table by a young and very inquisitive pathologist. Within the past year, the mutated gene central to this condition has been cloned and studies are underway to elucidate its normal immunologic function. This review summarizes our present state of knowledge of X-linked lymphoproliferative disease (XLP).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Purtilo DT, Yang JPS, Cassel CK, Harper R, Stephenson SR, Landing BH, Vawter GF. X-linked recessive progressive combined variable immunodeficiency (Duncan’s disease). Lancet 1975; 1: 935–941.

    Article  PubMed  CAS  Google Scholar 

  2. Harrington DS, Weisenburger DD, Purtilo DT. Epstein-Barr virus-associated lymphoproliferative lesions. Clin Lab Med 1988; 8: 97–118.

    PubMed  CAS  Google Scholar 

  3. Henle W, Henle G. The virus as the etiologic agent of infectious mononucleosis: In: Epstein MA, Achong BG (eds). The Epstein-Barr Virus. Berlin: Springer-Verlag, 1979, pp. 297–320.

    Chapter  Google Scholar 

  4. Evans AS, Neiderman JC, McCollum RW. Seroepidemiologic studies of infectious mononucleosis with EB virus. N Engl J Med 1968; 279: 1121–1127.

    Article  PubMed  CAS  Google Scholar 

  5. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 1984; 81: 4510–4514.

    Article  PubMed  CAS  Google Scholar 

  6. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984; 310: 1255–1230.

    Article  Google Scholar 

  7. Tosato G, Steinberg AD, Yarchoan R, Heilman CA, Pike SE, DeSean V, et al. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest 1984; 73: 1789–1795.

    Article  PubMed  CAS  Google Scholar 

  8. Gerber P, Nonyama M, Lucas S, Perlin E, Goldstein I. Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet 1972; 2: 988–989.

    Article  PubMed  CAS  Google Scholar 

  9. Tomkinson BE, Wagner DK, Nelson DL, Sullivan JL. Activated lymphocytes during acute Epstein-Barr virus infection. J Immunol 1987; 139: 3802–3807.

    PubMed  CAS  Google Scholar 

  10. Gross TG, Davis JR, Baker KS, Filipovich AH, Hinrichs SH, Pirruccello S, et al. Exaggerated IL-2 response to Epstein-Barr virus (EBV) in X-linked lymphoproliferative disease (XLP). Clin Immunol Immunopathol 1995; 75: 280–281.

    Google Scholar 

  11. Paul JR, Brunell WW. The presence of heterophile antibodies in infectious mononucleosis. Am J Med Sci 1932; 183: 90–104.

    Article  Google Scholar 

  12. Bartley DC, Del Rio C, Shulman JA. Clinical complications. In: Schlossberg D (ed). Infectious Mononucleosis. Berlin: Springer-Verlag, 1989, pp. 35–48.

    Chapter  Google Scholar 

  13. Wallace LE, Rickinson AB, Rowe M, Epstein MA. Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen. Nature 1982; 297: 413–415.

    Article  PubMed  CAS  Google Scholar 

  14. Pearson GR, On TW. Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens. J Natl Cancer Inst 1986; 56: 485–488.

    Google Scholar 

  15. Blazar BA, Patarroyo M, Klein E, Klein G. Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate. J Exp Med 1980; 151: 614–627.

    Article  PubMed  CAS  Google Scholar 

  16. Hasler F, Bluestein HG, Zvaifler NJ, Epstein LB. Analysis of the defects responsible for the impaired regulation of the Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes: I. Diminished gamma interferon production in response to autologous stimulation. J Exp Med 1983; 157: 173–188.

    Article  PubMed  CAS  Google Scholar 

  17. Mathur A, Kamat DM, Filipovich AH, Steinbuch M, Shapiro RS. Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferative disorders. Transplantation 1994; 57: 1042–1045.

    PubMed  CAS  Google Scholar 

  18. Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994; 330: 1185–1191.

    Article  PubMed  CAS  Google Scholar 

  19. Weisenburger DD, Purtilo DT. Failure in immunological control of the virus infection: fatal infectious mononucleosis. In: Epstein MA, Achong BG (eds). The Epstein-Barr Virus-Recent Advances. London: William Heinemann, 1986, pp. 127–161.

    Google Scholar 

  20. Okano M, Gross TG. Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol 1996; 53: 111–115.

    Article  PubMed  CAS  Google Scholar 

  21. Suyama CV. Epstein-Barr virus serologic testing: diagnostic indications and interpretations. Pediatr Infect Dis 1986; 5: 337–342.

    Article  Google Scholar 

  22. Greiner TC, Gross TG. Atypical immune lymphoproliferations. In: Hoffman (eds). Hematology: Basic Principles and Practice, 3rd edition Philadelphia: WB Saunders, 2000.

    Google Scholar 

  23. Hamilton JK, Paquin LA, Sullivan JL, Maurer HS, Cruzi PG, Provisor AJ, et al. X-linked lymphoproliferative syndrome registry report. J Pediatr 1980; 96: 669–673.

    Article  PubMed  CAS  Google Scholar 

  24. Seemayer TA, Gross TG, Egeler RM, Pirruccello SJ, Davis JR, Kelly CM, et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 1995; 38: 471–478.

    Article  PubMed  CAS  Google Scholar 

  25. Seemayer TA, Grierson H, Pirruccello SJ, Gross TG, Weisenberger DD, Davis J, et al. X-linked lymphoproliferative disease. Am J Dis Child 1993; 147: 1242–1245.

    PubMed  CAS  Google Scholar 

  26. Gross TG, Filipovich AH, Conley ME, Pracher E, Schmiegelow K, Verdirame JD, et al. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant 1996; 17: 741–744.

    PubMed  CAS  Google Scholar 

  27. Mroczek EC, Weisenburger DD, Grierson HL, Markin R, Purtilo DT. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 1987; 111: 530–535.

    PubMed  CAS  Google Scholar 

  28. Sullivan JL, Byron KS, Brewster FE, Baker SM, Ochs HD. X-linked lymphoproliferative syndrome: natural history of the immunodeficiency. J Clin Invest 1983; 71: 1765–1778.

    Article  PubMed  CAS  Google Scholar 

  29. Steinherz R, Levy Y, Litwin A, Nitzan M, Friedman E, Levin S. X-linked lymphoproliferative syndrome. Am J Dis Child 1985; 139: 191–193.

    PubMed  CAS  Google Scholar 

  30. Grierson H, Purtilo DT. Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome. Ann Intern Med 1987; 106: 538–545.

    PubMed  CAS  Google Scholar 

  31. Harrington DS, Weisenburger DD, Purtilo DT. Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer 1987; 59: 1419–1429.

    Article  PubMed  CAS  Google Scholar 

  32. Saemundsen AK, Purtilo DT, Sakamoto K, Sullivan JL, Synnerholm AC, Hanto D, et al. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative disease by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res 1981; 41: 4237–4242.

    PubMed  CAS  Google Scholar 

  33. Falk K, Ernberg I, Sakthivel R, Davis J, Christensson B, Luka J, et al. Expression of Epstein-Barr Virus-encoded proteins and B-cell markers in fatal infectious mononucleosis. Int J Cancer 1990; 46: 976–984.

    Article  PubMed  CAS  Google Scholar 

  34. Purtillo DT, Sakamoto K, Barnabei V, Seeley J, Bechtold T, Rogers G, et al. Epstein—Ban virus induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP) Am J Med 1982; 73: 49–56.

    Google Scholar 

  35. Egeler RM, de Kraker J, Slater R, Purtilo DT. Documentation of Burkitt lymphoma with t(8;14)(g24;g32) in X-linked lymphoproliferative disease. Cancer 1992; 70: 683–687.

    Article  PubMed  CAS  Google Scholar 

  36. Williams LL, Rooney CM, Conley ME, Brenner MK, Krance RA, Heslop HE. Correction of Duncan’s syndrome by allogeneic bone marrow transplantation. Lancet 1993; 2: 587–588.

    Article  Google Scholar 

  37. Turner AM, Berdoukas VA, Tobias VH, Ziegler JB, Toogood IR, Mulley JC, et al. Report on the X-linked lymphoproliferative disease in an Australian family. J Paediatr Child Health 1992; 28: 184–189.

    Article  PubMed  CAS  Google Scholar 

  38. Skare JC, Grierson HL, Sullivan JL, Nussbaum RL, Purtilo DT, Sylla BS, et al. Linkage analysis of seven kindreds with the X-linked lymphoproliferative syndrome (XLP) confirms that the XLP locus is near DSX42 and DXS37. Hum Genet 1989; 82: 354–358.

    PubMed  CAS  Google Scholar 

  39. Sanger WG, Grierson HL, Skare J, Wyandt H, Pinuccello S, Fordyce R, Purtilo DT. Partial Xq25 deletion in a family with the X-linked lymphoproliferative disease. Cancer Genet Cytogenet 1990; 47: 163–169.

    Article  PubMed  CAS  Google Scholar 

  40. Lanyi A, Li B, Ki S, Talmadge Cary Buresh, MD, Brichacek B, Davis JR, et al. A yeast artifical chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP). Genomics 1997; 39: 55–65.

    Article  PubMed  CAS  Google Scholar 

  41. Bolino A, Yin L. Seri M. Cusano R, Cinti R, Coffey A, et al. A new candidate region for the positional cloning of the XLP gene. Eur J Hum Genet 1998; 6: 509–517.

    Article  PubMed  CAS  Google Scholar 

  42. Coffey AJ, Brooksbank RA, Brandau O, Oohashi T, Howell GR, Bye JM, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 1998; 20: 129–135.

    Article  PubMed  CAS  Google Scholar 

  43. Cocks BG, Chang CC, Carballido JM, Yssel H, De Vries JE, Aversa G. A novel receptor involved in T-cell activation. Nature 1995; 376: 260–263.

    Article  PubMed  CAS  Google Scholar 

  44. Sayos J, Wu C, Mona M, Wang N, Zhang X, Allen D, et al. The X-linked lymphoproliferativedisease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998; 395: 462–469.

    Article  PubMed  CAS  Google Scholar 

  45. Nichols KE, Harkin DP, Levitz S, Krainer M, Kolquist KA, Genovese C, et al. Inactivating mutations in an SH2 domain encoding-gene in X-linked lymphoproliferative syndrome. Proc Natl Scad Sci USA 1998; 95: 13765–13770.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Thomas A. Seemayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timothy G. Greiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas G. Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jack R. Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Arpad Lanyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Janos Sumegi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Viral Epidemiology Branch, National Cancer Institute, 6120 Executive Blvd., Room 8012, MSC 7248, 20852, Rockville, MD, USA

    James J. Goedert MD (Chief) (Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Seemayer, T.A., Greiner, T.G., Gross, T.G., Davis, J.R., Lanyi, A., Sumegi, J. (2000). X-Linked Lymphoproliferative Disease. In: Goedert, J.J. (eds) Infectious Causes of Cancer. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-024-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-024-7_3

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9621-5

  • Online ISBN: 978-1-59259-024-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation